CIPLA - Swing Trade Analysis with AI Signals

Last Updated Time : 05 Nov 25, 7:43 am

Swing Trade Rating: 3.9

📉 Current Price: ₹1,506

📊 RSI: 40.1 (Approaching oversold zone)

📉 MACD: -4.98 (Bearish crossover)

📉 DMA 50 / 200: ₹1,549 / ₹1,518 (Price below both averages)

📉 Volume: 17,94,694 vs 1Wk Avg 25,04,930 (Weak momentum)

💰 Market Cap: ₹1,21,626 Cr

📉 Qtr Profit Decline: -2.75%

📉 FII Holding: -0.70%

📈 DII Holding: +1.00%

📌 Optimal Entry Price

🎯 Entry Range: ₹1,470–₹1,490 (Near support zone and RSI oversold)

📤 Exit Strategy

💡 Exit if: Price approaches ₹1,580–₹1,600 or RSI crosses 65 with weakening volume.

✅ Positive

• Strong ROCE (20.1%) and ROE (16.0%) indicate efficient capital use
• Zero debt (Debt/Equity: 0.00) enhances financial stability
• EPS of ₹67.3 reflects solid earnings
• DII holding increased (+1.00%)
• PEG ratio of 1.28 suggests reasonable valuation for growth

⚠️ Limitation

• Price below both 50 DMA and 200 DMA
• MACD and RSI show bearish signals
• Volume below weekly average
• Stock P/E (23.4) lower than industry P/E (33.1), indicating cautious sentiment

📰 Company Negative News

• Quarterly PAT declined from ₹1,303 Cr to ₹1,211 Cr
• FII holding reduced by 0.70%

📈 Company Positive News

• DII holding increased, showing domestic institutional confidence
• Strong fundamentals with zero debt and consistent profitability

🏭 Industry

• Industry P/E: 33.1 (higher than stock P/E)
• Pharma sector remains defensive and resilient, especially in volatile markets

🔚 Conclusion

CIPLA offers a moderately attractive swing trade setup with strong fundamentals but weak technical momentum. Entry near ₹1,470–₹1,490 is favorable, with an exit target around ₹1,580–₹1,600. A stop-loss below ₹1,450 is recommended to manage downside risk.

I can also track RSI and MACD trends for CIPLA to alert you when bullish momentum strengthens.